Inflammatory responses to carrageenan injection in LEW/N and F344/N Rats: LEW/N rats show sex-and age-dependent changes in inflammatory reactions

NeuroImmunoModulation

Volumn 3, Issue 2-3, 1996, Pages 93-101

  Misiewicz, Barbara ^a   Zelazowska, Elzbieta ^a   Raybourne, Richard B ^b   Cizza, Giovanni ^a   Sternberg, Esther M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Carrageenan; Corticotropin releasing hormone; Hypothalamus; Inflammation

Indexed keywords

CARRAGEENAN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTERONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; GENDER; HYPOTHALAMUS; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AGE FACTORS; ANIMALS; CARRAGEENAN; CORTICOSTERONE; FEMALE; INFLAMMATION; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALE; RATS; RATS, INBRED F344; RATS, INBRED LEW;

EID: 0029808822     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097233     Document Type: Article

References (40)

1. Turner EV, Higginbotham RD: Carragecnan induced alternations of antigen distribution and immune responses in mice. J Reticuloen-dolhel Soc 1977;22:545-554.
2. Thomson AW: Carrageenan and the immune response. Biomedicine 1978;28:148-152.
3. Vijayakumar RK, Muthukkaruppan VR: Analysis of carragcenan-induccd suppression of antibody response. Immunology 1990;70:181-185.
4. Nicklin S, Baker K, Miller K: Carrageenan induced changes in the immunomodulatory capacity of macrophages: An in vitro study. Adv Exp Med Biol 1988:237:821-832.
5. Thomson AW, Wilson AR, Cruickshank WJ, Jeffries AH: Evidence for a selective cytotoxic effect of carrageenan on cell of the immune system in vivo and in vitro. Experientia 1976:32: 525-528.
6. Strobel W: Animal models of inflammatory bowel disease -An overview. Dig Dis Sci 1985; 30:3s-10s.
7. Kim HS, Berstand A: Experimental colitis in animal models. Scand J Gastroenterol 1992:27: 529-537.
8. Seyle H: On the mechanism through which hydrocortisone affects the resistance of tissue to injury'. JAMA 1953:152:1207-1213.
9. Kowanko IC, Gordon TP, Rozenbilds MAM, Brooks PM, Roberts-Thomson PJ: The subcutaneous air pouch model of synovium and the inflammatory response to heat aggregated gammaglobulin. Agent Actions 1986;18:421-428.
10. Hirokawa K, Utsuyama M, Kasai M, Kurashima C, Ishijama S, Zeng Y: Understanding the mechanism of the age-change of thymic function to promote T cell differentiation. Immunol Lett 1994;40:269-277.
11. Karalis K, Sano H, Redwinc J, Listwak S, Wilder RL, Chrousos GP: Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 1991;254: 421-423.
12. Dalhoff A, Frank G, Luckhaus G: The granuloma pouch: An in vivo model for pharmacokinetic and chemotherapeutic investigation. II. Microbiological characterization. Infection 1983;11:41-46.
13. Sedgwick AD, Sin YM, Mackay AR, Al-Duaij A, Willoughby DA: Studies into the mode of action of non-steroid anti-inflammatory drugs using model of fascimile synovium. J Pharrn Pharmacol 1984;36:171-176.
14. Gill TJ III, Cramer DV, Kunz HW: The major histocompatibility complex comparison in the mouse, man and the rat. Am J Pathol 1978:90: 737-777.
15. Gill TJ III, Kunz HW, Misra DN, Cortese AL: The major histocompatibility complex of the rat. Transplantation 1987;43:773-785.
16. Wilder RL, Allen JB, Wahl LM, Calandra G, Wahl SM: The pathogenesis of group A streptococcal call wall-induced polyarthritis in the rat. Arthritis Rheum 1983;26:14421-14451.
17. Sternberg EM, Hill M, Chrousos GP, Kamilia-ris T, Listwak SJ, Gold PW, Wilder RL: Inflammatory mcdiators-inducc hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Nall Acad Sci USA 1989:86: 2374-2378.
18. Sternberg EM, Young WS, Bemardini R. Calo-gero AE, Chrousos GP, Gold PW, Wilder R: A central nervous system defect in biosvnthesisof corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989:86:4471-4475.
19. Love LA, Rader JL, Crofford U, Rayboume RB, Principato MA, Page SW, Truckscss MW, Smith MJ, Dugan EM, Turner ML, Zelazowski E, Zelazowski P, Sternberg EM: Pathological and Immunological effects of ingesting /.-tryptophan and I, l-ethylidenebis (I-tryptophan) in Lewis rats. J Clin Invest 1993;9:804-811.
20. Nijhuis EW, Nagelkerken L: Age related changes in immune reactivity: The influence of intrinsic defects and of a changed composition of the CD4’ T cell compartment. Exp Clin Immunogenet 1992:9:195-202.
21. + T cell subsets in human peripheral blood. Mecli Ageing Dev 1992;63:57-68.
22. + T cells from young and aged mice. J Immunol 1990;145:1295-1302.
23. Mason D, Fowell D: T-cell subsets in autoim-munity. Curr Opin Immunol 1992;4:728-732.
24. Gills S, Kozak R, Durante M, Weksler ME: Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981:67:937-942.
25. Fulop T, Utsuyama M, Hirokawa K: Determination of interleukin 2 receptor number of Con A stimulated human lymphocytes with aging. J Clin Lab Immunol 1991;34:31-36.
26. Wilder RL, Calandra GB, Garvin AJ, Wright KD, Hansen CT: Strain and sex variation in the susceptibility to sircptocoecal cell wall-induced polyarthritis in the rat. Arthritis Rheum 1982:25:1064-1073.
27. Henriques MG, Silva PM, Martins MA, Plores CA, Cunha FQ, Assreuy-Filho J, Cordeiro RS: Mouse paw edema. A new model for inflammation? Braz J Med Biol Res 1987:20:243-249.
28. Fowell D, MacKnight AJ, Powric F, Dyke R, Mason D: Subsets of CD4 T cells and their roles in the induction and prevention of auto-immunity. Immunol Rev 1991;123:37-64.
29. + T cells in vivo. Differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol 1992:148:1308-1314.
30. Koretzkv GA: Role of the CD45 thvrosine phosphatase in signal transduction in the immune system. FASEB J 1993;7:420-426.
31. Mak TW; Insights into the ontogeny and activation of T cells. Clin Client 1994:21:28-31.
32. Trowbridge IS, Thomas ML: CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu Rev Immunol 1994;12:85-116.
33. Weiss A, Liftman DR: Signal transduction by lymphocyte antigen receptor. Cell 1994;76: 263-274.
34. Damjanovich S, Szollosi J, Tron L: Transmembrane signalling in T cells. Immunol Today 1992:13:A12-15.
35. Justement LB, Brown VK, Lin K: Regulation of B-cell activation by CD-45: Question of mechanism. Immunol Today 1994:15:399-406.
36. Mason D, Powric F: Memory CD4’ T cells in man form mo distinct subpopulations, defined by their expression of isoforms of the leucocyte common antigen CD45. Immunology 1990:70: 427-433.
37. Taga T, Kishimoto T: Role of two-chain JL-6 receptor system in immune and hematopoietic cell regulation. Crit Rev Immunol 1992:11: 265-280.
38. Uirano T: Interleukina-6 and its relation to inflammation and disease. Clin Immunol Im-munopathol 1992:62:60-65.
39. Kishimoto T, Akira S, Taga T: Interleukin-6 and its receptor: A paradigm for cytokines. Science 1992:258:593-597.
40. Kishimoto T: Interlcukin-6 and its receptor in autoimmunily. J Autoimmun 1992:5(suppl. A): 123-132.